2 hours ago
Definium Therapeutics (DFTX) Stock Climbs Following White House Psychedelic Policy Shift
Definium Therapeutics (DFTX) stock rises after supporting White House psychedelic treatment policy. Stifel initiates coverage with $30 target, 34% upside.
The post Definium Therapeutics (DFTX) Stock Climbs Following White House Psychedelic Policy Shift appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
5 Dividend-Paying Stocks Positioned for Strong Performance Through 2028
- 2 hours ago
AST SpaceMobile (ASTS) Stock Tumbles 6% Amid Massive Insider Sales and Satellite...
- 2 hours ago
Market Preview: Tesla (TSLA) Earnings and Iran Diplomacy Dominate This Week’s Tr...
- 8 hours ago
Intel (INTC) Stock Soars 220% to 25-Year Peak Under New Leadership
- 8 hours ago
Amazon (AMZN) Stock Surges 20% in April as Cramer Favors It Over Microsoft (MSFT...
